Neurosecretion (Regulated Exocytosis)
The Basic Concept of Neurosecretion
In 1928, Ernst Scharrer accidentally discovered and hypothesized that there were large “glandular cells” in the preoptic region of the diencephalon of the fish, having secretory activity similar to that of endocrine gland cells. Lately confirmed by histochemical staining of neurons by Wolfgang Bargmann, neurosecretion was established.
Currently, neurosecretion is referred to as a physiological process of the storage, synthesis, and release of neuronal hormones. Since the neurosecretions from the neurons axonal terminals are transported and released to the outside of the neurons via dense core neurosecretory vesicles, this process is also known as regulated exocytosis. These secretory products, or neurohormones, synthesized and released from neurosecretory neurons circulate in the bloodstream and reach the target site of action, having a regulatory effect on both endocrine and nonendocrine cells. Therefore, neurosecretion has an important influence on brain structure, functions, and many other physiological responses.
Neurosecretory Vesicles for Exocytosis
Neurosecretory vesicles are dense-cored vesicles or electron-lucent synaptic vesicles produced in the cell body of neurosecretory neurons. Like other vesicles presenting in all cells, neurosecretory vesicles are synthesized in the rough endoplasmic reticulum, and transported to the Golgi for modification, condensing into immature vesicles. These precursor vesicles mature into neurosecretory vesicles of different sizes and shapes when they pass through axons or dendrites of neurons. Mature neurosecretory vesicles containing a major neurosecretory product usually bind to microtubules, which are responsible for transportation neurosecretory vesicles to the plasma membrane. The actin filaments on the plasma membrane of neuroendocrine neurons control the docking and exocytosis of neurosecretory vesicles.
Fig.1 Neurosecretory vesicle production, transport, and release in the neurosecretory neurons. (Morris, 2020)
Current Neurosecretory Model System
Currently, there are well-established neurosecretory systems that have been elucidated, one is the hypothalamic-neurohypophysial system, and the other is the hypothalamic-adenohypophyseal system, both of which play an important role in the regulation of brain function and other physiological activities.
The hypothalamic-neurohypophysial system, also known as the magnocellular neurosecretory system, consists of magnocellular neurosecretory neurons whose somata are in the supraoptic nucleus and paraventricular nucleus while nerve terminals located in the posterior pituitary. The magnocellular neurons synthesize and release neuropeptides (oxytocin and arginine vasopressin) into the circulation, both of which are critical factors for body fluid homeostasis and reproduction.
The hypothalamic-adenohypophyseal neurosecretory system, or the parvocellular neurosecretory system, synthesizes and releases several neurohormones, including 4 releasing hormones (growth hormone-releasing hormone, gonadotrophin-releasing hormone, thyrotrophin-releasing hormone, and corticotrophin-releasing hormone), Dopamine, and somatostatin. These neurohormones are widely implanted in a variety of physiological activities, such as stress response, growth, development, and metabolism.
Fig.2 Schematic illustration neurosecretory model systems. (Miyata, 2017)
As a recognized biotechnology company in CRO product and service providing, Creative Biolabs here provides a wide range of off-the-shelf products different neurosecretion research. Please feel free to contact us if you are interested or have any questions.
References
- Morris, J.F. Neurosecretory Vesicles: Structure, Distribution, Release and Breakdown. In: Neurosecretion: Secretory Mechanisms. Masterclass in Neuroendocrinology. 2020, 8: pp 81-102.
- Miyata, S.Advances in Understanding of Structural Reorganization in the Hypothalamic Neurosecretory System. Frontiers in Endocrinology (Lausanne). 2017, 8: 275.
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeuMab™ Anti-EPHB2 Antibody (NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-pTau Antibody (NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)